A public health task force is evaluating the performance of a newly developed rapid antigen test for diagnosing a regional tick-borne infection. During the validation trial, the test is administered to a cohort of patients who presented with suspected symptoms in an endemic region. A gold standard serological assay, performed simultaneously, confirms that patients in the cohort truly have the infection. The rapid antigen test yields a positive result in of the confirmed infected patients and a negative result in of the uninfected patients. A local primary care physician utilizes this rapid antigen test on a patient presenting with identical symptoms in the same endemic area. The test returns a positive result. Based on the validation trial data, which of the following best represents the approximate probability that this patient actually has the tick-borne infection?
- 67%Cevap
- B80%
- C88%
- D90%
- E95%